In MCL, CLL and WM, this medicine works by inhibiting the protein “Bruton tyrosine kinase”, a protein in the body that promotes the growth and survival of these cancer cells. By inhibiting this protein, ibrutinib helps kill cancer cells and their Reduce number. It also slows the worsening of the cancer.
IMBRUVICA 420 mg,28pcs
€9,236.70
The preparation is a medicine for the treatment of cancer that contains the active ingredient ibrutinib.
